1. Home
  2. CLGN vs BHV Comparison

CLGN vs BHV Comparison

Compare CLGN & BHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • BHV
  • Stock Information
  • Founded
  • CLGN 2004
  • BHV 2002
  • Country
  • CLGN Israel
  • BHV United States
  • Employees
  • CLGN N/A
  • BHV N/A
  • Industry
  • CLGN Industrial Specialties
  • BHV Finance/Investors Services
  • Sector
  • CLGN Health Care
  • BHV Finance
  • Exchange
  • CLGN Nasdaq
  • BHV Nasdaq
  • Market Cap
  • CLGN 19.1M
  • BHV 16.4M
  • IPO Year
  • CLGN N/A
  • BHV N/A
  • Fundamental
  • Price
  • CLGN $1.37
  • BHV $10.41
  • Analyst Decision
  • CLGN Strong Buy
  • BHV
  • Analyst Count
  • CLGN 2
  • BHV 0
  • Target Price
  • CLGN $11.50
  • BHV N/A
  • AVG Volume (30 Days)
  • CLGN 127.7K
  • BHV 3.5K
  • Earning Date
  • CLGN 08-19-2025
  • BHV 01-01-0001
  • Dividend Yield
  • CLGN N/A
  • BHV 3.35%
  • EPS Growth
  • CLGN N/A
  • BHV N/A
  • EPS
  • CLGN N/A
  • BHV N/A
  • Revenue
  • CLGN $2,472,000.00
  • BHV N/A
  • Revenue This Year
  • CLGN $2,177.67
  • BHV N/A
  • Revenue Next Year
  • CLGN $56.52
  • BHV N/A
  • P/E Ratio
  • CLGN N/A
  • BHV N/A
  • Revenue Growth
  • CLGN N/A
  • BHV N/A
  • 52 Week Low
  • CLGN $1.31
  • BHV $8.85
  • 52 Week High
  • CLGN $5.48
  • BHV $12.08
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 39.49
  • BHV 53.95
  • Support Level
  • CLGN $1.35
  • BHV $10.32
  • Resistance Level
  • CLGN $1.54
  • BHV $10.43
  • Average True Range (ATR)
  • CLGN 0.14
  • BHV 0.07
  • MACD
  • CLGN -0.02
  • BHV 0.01
  • Stochastic Oscillator
  • CLGN 2.88
  • BHV 55.88

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About BHV BlackRock Virginia Municipal Bond Trust

Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes.

Share on Social Networks: